Results for rere translation from French to English

rere
rère

* "more maori lessons", taira rere.
* "more maori lessons", by taira rere.

(*) vice-chancelier de l'université de rere.
(*) vice-chancellor of the makerere univer­sity (uganda).

* "conversational maori, rarotongan language", taira rere.
* "conversational maori, rarotongan language", by taira rere.

* "maori lessons for the cook islands", taira rere.
* "maori lessons for the cook islands", by taira rere.

de nombreux endroits fascinants vous attendent à quelques encablures, dont rere bay avec ses chutes d'eau et ses sentiers de randonnée.
many fascinating places await a stone's throw away, including rere bay, with its waterfalls and footpaths.

la présente invention concerne la régulation de l'activation et de la migration des lymphocytes. plus particulièrement, la présente invention concerne des acides nucléiques codant les acides nucléiques et les protéines répertoriés dans la figure 7, impliqués dans la modulation de l'activation et de la migration des lymphocytes, par exemple, a-raf-1, lck, zap70, syk, plcΩη1, pag, shp/ptp1c, csk, nucléoline, slap, pak2, trac1, tcptp/ptpn2, edg1, il10-rα, intégrineα2, enolase 1a, prsm1, cln2, p2x5b, 6pfkl, dusp1, kiaa0251, gg2-1, grb7, sh2-b, stat1, tcf19, hfp101s, rere, sudd, ku70, scamp2, fibuline-5, kiaa1228, est du clone 2108068, vimentine, filamine a α, centractine α, moésine, timp3 et rnh. l'invention concerne également des méthodes d'identification et d'utilisation d'agents, notamment de petites molécules organiques, d'anticorps, de peptides, de peptides cycliques, d'acides nucléiques, d'acides nucléiques antisens, d'arnsi et de ribozymes, qui modulent l'activation ou la migration des lymphocytes; ainsi que l'utilisation de profils d'expression et de compositions dans le diagnostic et le traitement associés à l'activation et à la suppression des lymphocytes et à la migration des lymphocytes.
the present invention relates to regulation of lymphocyte activation and migration. more particularly, the present invention is directed to nucleic acids encoding the nucleic acids and proteins listed in figure 7, which are involved in modulation of lymphocyte activation and migration, e.g., a-raf-1, lck, zap70, syk, plcγ1, pag, shp/ptp1c, csk, nucleolin, slap, pak2, trac1, tcptp/ptpn2, edg1, il10-rα, integrinα2, enolase 1a, prsm1, cln2, p2x5b, 6pfkl, dusp1, kiaa0251, gg2-1, grb7, sh2-b, stat1, tcf19, hfp101s, rere, sudd, ku70, scamp2, fibulin-5, kiaa1228, est from clone 2108068, vimentin, filamin a α, centractin α, moesin, timp3, and rnh. the invention further relates to methods for identifying and using agents, including small organic molecules, antibodies, peptides, cyclic peptides, nucleic acids, antisense nucleic acids, sirna, and ribozymes, that modulate lymphocyte activation or migration; as well as to the use of expression profiles and compositions in diagnosis and therapy related to lymphocyte activation and suppression, and lymphocyte migration.